Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
How Pharma Marketing Can Evolve Beyond Audience Targeting
Kamya Elawadhi is Co-Founder and President at Doceree. For the better part of a decade, pharma marketing has pursued one goal above all others: Know the audience. Look-alike models were built on claims data. National provider identifier-level…
Big Pharma Is Hooked on Chinese Licensing Deals
Merck & Co. executives were excited. They were working on a drug that had the potential to become a “cornerstone” treatment for cancer, with 17 late-stage trials pitting it against lung, breast and other tumors. “It is one of…
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?
The Invesco Pharmaceuticals ETF (PJP +1.38%) offers concentrated exposure to U.S. drugmakers, while the Invesco Nasdaq Biotechnology ETF (IBBQ +0.93%) provides a broader, lower-cost gateway to the biotechnology and pharmaceutical sectors. Both…
At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings
The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat... To view the full…
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
The VanEck Pharmaceutical ETF (PPH +1.86%) offers concentrated exposure to established global drugmakers and higher yields, while the State Street SPDR S&P Biotech ETF (XBI -0.20%) provides a diversified, higher-volatility play on smaller-cap…
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since 2021, enabling the Company to provide a broad…
Invesco MF launches India Pharma and Healthcare NFO
Invesco Mutual Fund has launched India Pharma and Healthcare Fund which will invest across pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organisations, contract research organisations, medical devices…
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
KLRA trades 29% below its IPO high but holds $1.17 billion in cash and carries a $42 analyst consensus price target. Merck's looming Keytruda revenue cliff and Novo Nordisk's need to defend Wegovy dominance make both natural buyers of Kailera's…
Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year High - Here's Why
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares hit a new 52-week high on Wednesday. The stock traded as high as $40.17 and last traded at $38.86, with a volume of 194791 shares. The stock had previously closed at $38.25. AVLN has been…
Commerzbank Aktiengesellschaft FI Invests $1.20 Million in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,407 shares…
Ascendis Pharma A/S (NASDAQ:ASND) Director Jean Jacques Bienaime Purchases 2,000 Shares of Stock
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) Director Jean Jacques Bienaime purchased 2,000 shares of the company's stock in a transaction on Friday, August 14th. The stock was acquired at an average cost of $246.33 per share, for a total…
Is Big Pharma Already Stalling Trump's Vaccine Executive Order?
The term is called running the clock…stalling….buying time. Splitting the measles, mumps, rubella (MMR) vaccine into separate [monovalent] shots could now take 10 years according to mainstream reporting. A decade to make a presumably…
Indian Stock Market Declines Amidst Soaring Crude Oil Prices & US-Iran Ceasefire Expiry
Indian benchmark equity indices, Sensex and Nifty, witnessed a decline in early trade as elevated crude oil prices and persistent geopolitical uncertainties, particularly the expiry of the US-Iran ceasefire, dampened investor sentiment. Indian…
/afaqs/media/media_files/2026/08/19/socio-2026-08-19-13-58-15.jpg)
SocioClout appoints Niyati Desai as AVP- growth
Niyati Desai has joined integrated marketing agency SocioClout as associate vice president- growth. She will lead the agency's Mumbai business. Announcing her new role on LinkedIn, Desai said: “I'm excited to share that I'm joining…
AI isn't close to curing cancer. This startup says it knows what it will take.
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it. HIVE, modular robotic labs built by the company, can grow 20 kinds of human tissue, then autonomously dose and…
Receive a Daily briefing on Pharma Industry News
Get Started